PepGen Inc.
corporate_fare Company Profile
PepGen Inc. (NASDAQ:PEPG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for PEPG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for PEPG spans 4, 10-Q, 8-K, S-3.
Recent high-impact activity:
- RA Capital Buys $43.1M of PepGen Stock at the $5.00 Offering Price
- PepGen Prices $125M Offering at $5.00, a Discount to Tuesday's Close
- PepGen Seeks $125M Equity Raise Hours After Positive Phase 2 Data
- PepGen Q3 Cash Falls to $104.8M; Runway Extended Into 2028 on FREEDOM2 Data
- PepGen's DM1 Drug Hits 46.5% Splicing Correction in Phase 2, Best Reported to Date
Financial Snapshot
Short Interest & Short Volume
2.83 days to coverFINRA reported short interest of 3,367,041 shares in PEPG as of the October 30, 2026 settlement, a 11.5% decrease from the prior period — about 2.8 days to cover at its recent average daily volume. On November 20, 2026, 52.0% of PEPG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PEPG, detected from its recent SEC filings · based on capital-structure filings through 2026-11-10.
Preliminary Terms for $125M Offering · Underwriters and 30-Day Option
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →